Castle Biosciences, Inc. · NASDAQ:CSTL

Oelschlager Kristen M sold 8,587 Castle Biosciences, Inc. shares (Form 4)

Traded Jun 16, 2026 · Filed Jun 18, 2026

On Jun 16, 2026, Oelschlager Kristen M (Chief Operating Officer) sold 8,587 Castle Biosciences, Inc. shares at US$20.71 for US$178K under a trading plan, leaving 30,460 shares. Filed Jun 18, 2026 (Form 4).

Sold
8,587 shares
Price
US$20.71
Value
US$178K
Holding after
30,460 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 16, 2026Common StockSale8,587US$20.7130,460Direct

Source

View original at SEC

Related